Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Iloprost for Sarcoidosis Associated Pulmonary Hypertension
NCT00403650Phase 4Completed
- Sponsor
- University of Cincinnati
- Start
- Nov 2006
- Primary completion
- Jul 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of iloprost in pulmonary arterial hypertension (PAH), sponsored by University of Cincinnati. Started Nov 2006; status: completed.
02
Drugs
iloprost
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00403650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403650.